REFERENCES

• American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association1994
   Google Scholar
• World Health Organization.The ICD-10 Classification of Mental and Behavioral Disorders. Clinical descriptions and diagnostic guidelines. Geneva, Switzerland: World Health Organization1992
   Google Scholar
• KershnerP.Wang-ChengR.Psychiatric side effects of steroid therapy.Psychosomatics.1989301351392652177
   PubMed Web of Science ®Google Scholar
• ConnorTJ.LeonardBE.Depression, stress and immunological activation: the role of cytokines in depressive disorders.Life Sci.1998625836069472719
   PubMed Web of Science ®Google Scholar
• LevineJ.BarakY.ChengappaKN.RapoportA.RebeyM.BarakV.Cerebrospinal cytokine levels in patients with acute depressionNeuropsychobiology.199940 17117610559698
   PubMed Web of Science ®Google Scholar
• ConnorTJ.HarkinA.KellyJP.LeonardBE.Olfactory bulbectomy provokes a suppression of interleukin-1beta and tumour necrosis factor-alpha production in response to an in vivo challenge with lipopolysaccharide: effect of chronic desipramine treatment.Neuroimmunomodulation.20007273510601816
   PubMed Web of Science ®Google Scholar
• RidtitidW.WongnawaM.MahatthanatrakulW.ChaipolP.SunbhanichM.Effect of rifampin on plasma concentrations of mefloquine in healthy volunteers.J Pharm.20005212651269
   Google Scholar
• RodorF.BianchiG.GrignonS.SamuelianJC.JouglardJ.Recurrent psychiatric manifestations during malaria prevention with mefloquine. A case report [in French].Thérapie.199045433434
   PubMedGoogle Scholar
• LysackJT.LysackCL.KvernBL.A severe adverse reaction to mefloquine and chloroquine prophylaxis.Aust Fam Physician.199827111911209919736
   PubMedGoogle Scholar
• DukesMNG.AronsonJK.eds.Meyler's Side Effects of Drugs. 14th ed. Amsterdam, The Netherlands: Elsevier2000956957
   Google Scholar
• FlockhartDA.Cytochrome P450 drug interaction table. Homepage of the Indiana University Department of Medicine. Available at http://medicine.iupui.edu/flockhart December 2002. Accessed 18 April 2003.
   Google Scholar
• StrainJJ.ChiuNM.BrodskyM.KarïmA.CaliendoG.Comparison of three methods for identifying medical drugpsychotropic drug interactions.Gen Hosp Psychiatry.20022431131512220796
   PubMed Web of Science ®Google Scholar
• SittigDF.JimisonHB.HazlehurstBL.et al.Techniques for identifying the applicability of new information management technologies in the clinical setting: an example focusing on handheld computers.Proc AMIA Symp.200080480811079995
   PubMedGoogle Scholar
• MarshJC.ChowdryJ.Parry-JonesN.et al.Study of the association between cytochromes P450 2D6 and 2E1 genotypes and the risk of drug and chemical induced idiosyncratic aplastic anaemia.Br J Haematol.199910426627010050706
   PubMed Web of Science ®Google Scholar
• BertilssonL.Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19.Clin Pharmacokinet.1995291922098521680
   PubMed Web of Science ®Google Scholar
• KohenM.AshersonRA.GharaviAE.LahitaRG.Lupus psychosis: differentiation from the steroid-induced state.Clin Exp Rheumatol.1993113233268353989
   PubMed Web of Science ®Google Scholar
• HausnerRS.Amantadine-associated recurrence of psychosis.Am J Psychiatry.19801372402427352586
   PubMed Web of Science ®Google Scholar
• LiebK.HufertFT.BechterK.BauerJ.KornhuberJ.Depression, Borna disease, and amantadine.Lancet.19973499589093281
   PubMed Web of Science ®Google Scholar
• RegoMD.GillerEL Jr.Mania secondary to amantadine treatment of neuroleptic-induced hyperprolactinemia.J Clin Psychiatry.1989501431442564388
   PubMed Web of Science ®Google Scholar
• MuIIerHF.DastoorDP.KlingnerA.ColeM.BoillatJ.Amantadine in senile dementia: electroencephalographic and clinical effects.J Am Geriatr Soc.197927916759472
   PubMed Web of Science ®Google Scholar
• FannJR.Psychiatric effects of neuropharmacological agents.Semin Clin Neuropsychiatry.2002720621212111675
   PubMedGoogle Scholar
• [No authors listed]. Drugs that may cause psychiatric symptoms.Med Lett Drugs Ther.200244596212138379
   PubMed Web of Science ®Google Scholar
• TolnaiA.BaresI.NagyE.KaliG.Complication of aminoglycoside therapy: acute psychosis and renal insufficiency.Orv Hetil.1984125304730506514346
   PubMedGoogle Scholar
• KaneFJ Jr.ByrdG.Acute toxic psychosis associated with gentamicin therapy.South Med J.19756812831285809844
   PubMed Web of Science ®Google Scholar
• SrisurapanontM.KittiratanapaiboonP.JarusuraïsinN.Treatment for amphetamine psychosis.Cochrane Database Syst Rev.20014CD00302611687172
   PubMedGoogle Scholar
• YuiK.IkemotoS.IshiguroT.GotoK.Studies of amphetamine or methamphetamine psychosis in Japan: relation of methamphetamine psychosis to schizophrenia.Ann N Y Acad Sci.200091411211085303
   PubMed Web of Science ®Google Scholar
• FlaumM.SchultzSK.When does amphetamine-induced psychosis become schizophrenia?Am J Psychiatry.19961538128158633695
   PubMed Web of Science ®Google Scholar
• CaplehornJR.Amphetamine psychosis.Br J Addict.199085150515062095767
   PubMedGoogle Scholar
• HallRC.PopkinMK.BeresfordTP.HallAK.Amphetamine psychosis: clinical presentations and differential diagnosis.Psych iatr Med.198867379
   Google Scholar
• KokkinidisL.ZacharkoRM.Response sensitization and depression following long-term amphetamine treatment in a self-stimulation paradigm.Psychopharmacology (Berl),19806873766771800
   PubMed Web of Science ®Google Scholar
• MaloneDAJr.DimeffRJ.LombardoJA.SampleRH.Psychiatric effects and psychoactive substance use in anabolic-androgenic steroid users.Clin J Sport Med.1995525317614077
   PubMed Web of Science ®Google Scholar
• PopeHG Jr.KatzDL.Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes.Arch Gen Psychiatry.1994513753828179461
   PubMed Web of Science ®Google Scholar
• WeissEL.BowersMB Jr.MazureCM.Testosterone-patch-induced psychotic mania.Am J Psychiatry.199915696910360145
   PubMed Web of Science ®Google Scholar
• OgaK.KojimaT.MatsuuraM.et al.Effects of low-dose ketamine on neuropathic pain: an electroencephalogram-electrooculogram/behavioral study.Psychiatry Clin Neurosci.20025635536312109952
   PubMed Web of Science ®Google Scholar
• PalHR.BerryN.KumarR.RayR.Ketamine dependence.Anaesth Intensive Care.20023038238412075653
   PubMed Web of Science ®Google Scholar
• ChristensenRC.Misdiagnosis of anticholinergic delerium as schizophrenic psychosis.Am J Emerg Med.1995131171187832941
   PubMed Web of Science ®Google Scholar
• HvizdosAJ.BennettJA.WellsBG.RappaportKB.MendelSA.Anticholinergic psychosis in a patient receiving usual doses of haloperidol, desipramine, and benztropine.Clin Pharm.198321741786883947
   PubMedGoogle Scholar
• HallRC.FeinsilverDL.HoltRE.Anticholinergic psychosis: differential diagnosis and management.Psychosomatics.198122581583; 5877267948
   PubMed Web of Science ®Google Scholar
• PerryPJ.WildingDC.JuhlRP.Anticholinergic psychosis.Am J Hosp Pharm.197835725728665688
   PubMedGoogle Scholar
• LeeJH.urndorfH.PoppersPJ.Physostigmine reversal of antihistamineinduced excitement and depression.Anesthesiology.197543683684242240
   PubMed Web of Science ®Google Scholar
• lannacconeR.SueYJ.vnerJR.Suicidal psychosis secondary to isoniazid.Pediatr Emerg Care.200218252711862134
   PubMed Web of Science ®Google Scholar
• DjiboA.LawanA.Behavioral disorders after treatment with isoniazid.Bull Soc Pathol Exot.20019411211411475027
   PubMed Web of Science ®Google Scholar
• ChanTY.Pyridoxine ineffective in isoniazid-induced psychosis.Ann Pharmacother.1999331123112410534228
   PubMed Web of Science ®Google Scholar
• HsuCW.ChuKA.LuT.LaiRS.LuJY.Ethambutol-induced psychosis: a case report.Zhonghua Yi Xue Za Zhi (Taipei).19996272472710533303
   PubMedGoogle Scholar
• SalafiaA.CandidaRifampicin induced flu-syndrome and toxic psychosis.Indian J Lepr.1992645375391308530
   PubMedGoogle Scholar
• PoulsenHD.LublinHK.Efavirenz-induced psychosis leading to involuntary detention.AIDS.20031745145312556706
   PubMed Web of Science ®Google Scholar
• de la GarzaCL.Paoletti-DuarteS.Garcia-MartinC.Gutierrez-CasaresJR.Efavirenz-induced psychosis.AIDS.2001151911191211579266
   PubMed Web of Science ®Google Scholar
• HansenBA.GreenbergKS.RichterJA.Ganciclovir-induced psychosis.N Engl J Med.199633513978927071
   PubMed Web of Science ®Google Scholar
• BonaccorsoS.MarinoV.BiondiM.GrimaldiF.IppolitiF.MaesM.Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus.J Affect Disord.20027223724112450640
   PubMed Web of Science ®Google Scholar
• Lana-PeixotoMA.TeixeiraAL Jr.aaseVG.Interferon beta-1a-induced depression and suicidal ideation in multiple sclerosis.Arq Neuropsiquiatr.20026072172412364937
   PubMed Web of Science ®Google Scholar
• TamamL.YerdelenD.OzpoyrazN.Psychosis associated with interferonalfa therapy for chronic hepatitis B.Ann Pharmacother.20033738438712639168
   PubMed Web of Science ®Google Scholar
• Garcia-ParesG.DomenechC.GilM.Psychosis induced by interferonalpha.Psychosomatics.20024342842912297615
   PubMed Web of Science ®Google Scholar
• KornischkaJ.BurtscheidtW.aebelW.Interferon-induced paranoid psychosis. Review of the literature and case report.Nervenarzt.20027346346712078026
   PubMed Web of Science ®Google Scholar
• NakagawaY.IshïmaT.IshïbashïY.TsujiM.TakashimaT.Involvement of GABAb receptor systems in experimental depression: baclofen but not bicuculline exacerbates helplessness in rats.Brain Res.19967412402459001728
   PubMed Web of Science ®Google Scholar
• SommerBR.PetridesG.A case of baclofen-induced psychotic depression.;Clin Psychia try.199253211212
   PubMed Web of Science ®Google Scholar
• YassaRY.IskandarHL.Baclofen-induced psychosis: two cases and a review.J Clin Psychiatry.1988493183203045103
   PubMed Web of Science ®Google Scholar
• KirubakaranV.MayfieldD.RengacharyS.Dyskinesia and psychosis in a patient following baclofen withdrawal.Am J Psychiatry.19841416926936711693
   PubMed Web of Science ®Google Scholar
• ArnoldES.RuddSM.KirshnerH.Manic psychosis following rapid withdrawal from baclofen.Am J Psychiatry.1980137146614677435695
   PubMed Web of Science ®Google Scholar
• SarrecchïaC.SordilloP.ConteG.RocchiG.Barbiturate withdrawal syndrome: a case associated with the abuse of a headache medication [in Italian].Ann Ital Med Int.19981323723910349206
   PubMedGoogle Scholar
• ModellJG.Protracted benzodiazepine withdrawal syndrome mimicking psychotic depression.Psychosomatics.1997381601619063050
   PubMed Web of Science ®Google Scholar
• TeraoT.TaniY.Two cases of psychotic state following normal-dose benzodiazepine withdrawal.J UOEH.1988103373402902678
   PubMedGoogle Scholar
• HuguesFC.JouglardJ.Le JeunneC.oulinM.BegaudB.Psychotic disorders linked to the inhibition of benzodiazepine catabolism.Rev Med Intern.19878433436
   PubMed Web of Science ®Google Scholar
• LoveJN.HandlerJA.Toxic psychosis: an unusual presentation of propranolol intoxication.Am J Emerg Med.1995135365377662058
   PubMed Web of Science ®Google Scholar
• CunnaneJG.BlackwoodGW.Psychosis with propranolol: still not recognized?Postgrad Med J.19876357583671231
   PubMed Web of Science ®Google Scholar
• ParkerWA.Propranolol-induced depression and psychosis.Clin Pharm.198542142183987222
   PubMedGoogle Scholar
• McGahanDJ.WojslawA.PrasadV.BlankenshipS.Propranolol-induced psychosis.Drug Intell Clin Pharm.1984186016036745087
   PubMedGoogle Scholar
• RemickRA.O'KaneJ.SparlingTG.A case report of toxic psychosis with low-dose propranolol therapy.Am J Psychiatry.19811388508517246824
   PubMed Web of Science ®Google Scholar
• ViaderoJJ.WongSH.WhiteWB.Acute psychotic behavior associated with atenolol.Am J Psychiatry.198314013826624977
   PubMed Web of Science ®Google Scholar
• PétrieWM.MaffucciRJ.WoosleyRL.Propranolol and depression.Am J Psychiatry.198213992947055283
   PubMed Web of Science ®Google Scholar
• ShoreJH.FraunfelderFT.MeyerSM.Psychiatric side effects from topical ocular timolol, a beta-adrenergic blocker.J Clin Psychopharmacol.98772642673624510
   PubMed Web of Science ®Google Scholar
• SorensenHT.MellemkjaerL.OlsenJH.Risk of suicide in users of beta-adrenoceptor blockers, calcium channel blockers and angiotensin-converting enzyme inhibitors.Br J Clin Pharmacol.20015231331811560564
   PubMed Web of Science ®Google Scholar
• SchweitzerI.MaguireK.TuckwellV.Antiglaucoma medication and clinical depression.Aust N Z J Psychiatry.20013556957111551270
   PubMed Web of Science ®Google Scholar
• ReevesRR.PïnkofskyHB.Postpartum psychosis induced by bromocriptine and pseudoephedrine.J Fam Pract.1997451641669267376
   PubMed Web of Science ®Google Scholar
• JimenoValdesA.Ruiz OtazoAM.Jimeno BulnesN.A case of toxic psychosis caused by bromocriptine [in Spanish].Adas Luso Esp Neurol Psiquiatr CiencAfines.198917386390
   PubMedGoogle Scholar
• IffyL.LindenthalJ.SzodiZ.GriffinW.Puerperal psychosis following ablaction with bromocriptine.Med Law.198981711742516595
   PubMedGoogle Scholar
• CanterburyRJ.HaskïnsB.KahnN.SaathoffG.YazelJJ.Postpartum psychosis induced by bromocriptine.South Med J.198780146314643686155
   PubMed Web of Science ®Google Scholar
• BoydA.Bromocriptine and psychosis: a literature review.Psychiatr Q.19956687957701022
   PubMed Web of Science ®Google Scholar
• VinckenW.Psychotic reaction to cefuroxime.Lancet.198419656143902
   PubMed Web of Science ®Google Scholar
• SakerBM.MuskAW.HaywoodEF.HurstPE.Reversible toxic psychosis after cephalexin.Med J Aust.197314974984700536
   PubMed Web of Science ®Google Scholar
• HeineckeG.HofflerU.FinkeK.Reversible encephalopathy following cephacetril therapy in high doses in a patient on chronic intermittent hemodialysis.Clin Nephrol.1976545471248185
   PubMedGoogle Scholar
• GargP.ModyP.LallKB.Toxic psychosis due to chloroquine - not uncommon in children.Clin Pediatr.199029448450
   PubMed Web of Science ®Google Scholar
• NicolasX.GranierH.AdamF.LabordeJP.TalarminF.KlotzF.Acute psychosis following treatment with chloroquine for a primo-invasion of Plasmodium vivax malaria [in French].Presse Med.20033211712610381
   PubMed Web of Science ®Google Scholar
• BhatiaMS.Chloroquine-induced recurrent psychosis (brief report).Indian J Med Sci.1996503023049141350
   PubMedGoogle Scholar
• MassonC.CheronF.GautierMS.CambierJ.Acute psychosis after ingestion of chloroquine.Presse Med.1990193342138305
   PubMed Web of Science ®Google Scholar
• AgrawalA.AgrawalR.Chloroquine-induced psychosis.Indian Pediatr.198825122612273251847
   PubMedGoogle Scholar
• AkhtarS.MukherjeeS.Chloroquine-induced mania.Int J Psychiatry Med.1993233493568175247
   PubMed Web of Science ®Google Scholar
• LovestoneS.Chloroquine-induced mania.Br J Psychiatry.19911591641651888972
   PubMed Web of Science ®Google Scholar
• BoudreauE.SchusterB.SanchezJ.etal.Tolerability of prophylactic Lariam regimens.Trop Med Parasitol.1993442572658256107
   PubMedGoogle Scholar
• EngînarN.ErogluL.The long-term clonidine treatment induced behavioral depression in rats.Pol J Pharmacol Pharm.1990424094152098750
   PubMedGoogle Scholar
• KostowskïW.ObersztynM.Chronic administration of desipramine and imipramine but not zimelidine attenuates clonidine-induced depression of avoidance behavior in rats.Pol J Pharmacol Pharm.1988403413492851779
   PubMedGoogle Scholar
• TerkelsenKG.Mania after surreptitious discontinuation of clonidine.Am J Psychiatry.19841411536581736
   PubMed Web of Science ®Google Scholar
• AdlerLE.BellJ.KirchD.FriedrichE.FreedmanR.Psychosis associated with clonidine withdrawal.Am J Psychiatry.19821391101126119907
   PubMed Web of Science ®Google Scholar
• ElïzurA.LibersonZ.An acute psychotic episode at the beginning of clonidine therapy. 1.Prog Neuropsychopharmacol.198042112137403354
   PubMedGoogle Scholar
• BrownES.KhanDA.NejtekVA.The psychiatric side effects of corticosteroids.Ann Allergy Asthma Immunol.199983(6 Pt 1)495503Quiz. 50350410619339
   PubMed Web of Science ®Google Scholar
• LewisDA.SmithRE.Steroid-induced psychiatric syndromesa report of 14 cases and a review of the literature.J Affect Disord.198353193326319464
   PubMed Web of Science ®Google Scholar
• MerrillW.Case 35-1998: use of lithium to prevent corticosteroidinduced mania.N Engl J Med.1999340112310206839
   PubMed Web of Science ®Google Scholar
• GoggansFC.WeisbergLJ.KoranLM.Lithium prophylaxis of prednisone psychosis: a case report.J Clin Psychiatry.1983441111126403514
   PubMed Web of Science ®Google Scholar
• Sabet-SharghiF.HutzlerJC.Prophylaxis of steroid-induced psychiatric syndromes.Psychosomatics.1990311131142300649
   PubMed Web of Science ®Google Scholar
• AbbasA.StyraR.Valproate prophylaxis against steroid-induced psychosis.Can J Psychiatry.1994391881898033028
   PubMed Web of Science ®Google Scholar
• PattenSB.Exogenous corticosteroids and major depression in the general population.J Psychosom Res.20004944744911182439
   PubMed Web of Science ®Google Scholar
• PattenSB.WilliamsJV.LoveEJ.Self-reported depressive symptoms following treatment with corticosteroids and sedative-hypnotics.Int J Psychiatry Med.19962615248707452
   PubMed Web of Science ®Google Scholar
• DeSilvaCC.NurseMC.VokeyK.Steroid-induced psychosis treated with risperidone.Can J Psychiatry.20024738838912025444
   PubMed Web of Science ®Google Scholar
• Lopez-MedranoF.CerveraR.TrejoO.FontJ.IngelmoM.Steroidinduced psychosis in systemic lupus erythematosus: a possible role of serum albumin level.Ann Rheum Dis.20026156256312006338
   PubMed Web of Science ®Google Scholar
• MesuroIIeB.AricheM.CohenD.Premedication before IV contrastenhanced CT resulting in steroid-induced psychosis.AJR Am J Roentgenol.200217876676711856719
   PubMed Web of Science ®Google Scholar
• LeeKM.LinYZ.HuangFY.Steroid-induced acute psychosis in a child with asthma: report of one case.Acta Paediatr Taiwan.20014216917111431864
   PubMedGoogle Scholar
• DawsonKL.CarterER.A steroid-induced acute psychosis in a child with asthma.Pediatr Pulmonol.1998263623649859907
   PubMed Web of Science ®Google Scholar
• BrockingtonIF.BrownellLW.Steroid-induced prepartum psychosis.Br J Psychiatry.1997170909068786
   PubMed Web of Science ®Google Scholar
• BlochM.GurE.ShalevA.Chlorpromazine prophylaxis of steroidinduced psychosis.Gen Hosp Psychiatry.19941642448039683
   PubMed Web of Science ®Google Scholar
• MullenRS.Romans-CIarksonSE.Behavioural sensïtïsatïon and steroidinduced psychosis.Br J Psychiatry.19931625495518481750
   PubMedGoogle Scholar
• WadaK.YamadaN.SatoT.et al.Corticosteroid-induced psychotic and mood disorders: diagnosis defined by DSM-IV and clinical pictures.Psychosomatics.20014246146611815680
   PubMed Web of Science ®Google Scholar
• SutorB.WellsLA.RummansTA.Steroid-induced depressive psychosis responsive to electroconvulsive therapy.Convuls Ther.1996121041078744170
   PubMedGoogle Scholar
• PiesR.Differential diagnosis and treatment of steroid-induced affective syndromes.Gen Hosp Psychiatry.1995173533618522150
   PubMed Web of Science ®Google Scholar
• CarneyMW.RappS.PearceK.Digoxin toxicity presenting with psychosis in a patient with chronic phobic anxiety.Clin Neuropharmacol.198581931954005868
   PubMed Web of Science ®Google Scholar
• SinghRB.SinghVP.SomanïPN.Psychosis: a rare manifestation of digoxin intoxication.J Indian Med Assoc.1977696263608981
   PubMedGoogle Scholar
• ChyrekR.JableckaA.Pupek-MusialikD.LowickiZ.Digoxin as a cause of chromatopsia and depression in a patient with heart failure and hyperthyroidism.Pol Merkuriusz Lek.20009563564
   PubMedGoogle Scholar
• MurthyKK.Psychosis during disulfiram therapy for alcoholism.J Indian Med Assoc.19979580819212576
   PubMedGoogle Scholar
• RossiterSK.Psychosis with disulfiram prescribed under probation order.BMJ.19923057631422334
   PubMedGoogle Scholar
• GoyerPF.BrownGL.MinichielloMD.MajorLF.Mood-altering effects of disulfiram in alcoholics.J Stud Alcohol.1984452092136748661
   PubMed Web of Science ®Google Scholar
• DebïenC.De Chouly De LenclaveMB.FoutreinP.BaillyD.Alpha-interferon and mental disorders [in French].Encéphale.200127308317
   PubMed Web of Science ®Google Scholar
• CasteraL.ZiganteF.BastieA.BuffetC.DhumeauxD.HardyP.Incidence of interferon-alfa-induced depression in patients with chronic hepatitis C.Hepatology.20023597897911915051
   PubMed Web of Science ®Google Scholar
• MusselmanDL.LawsonDH.GumnïckJF.etal.Paroxetine for the prevention of depression induced by high-dose interferon-alfa.N Engl J Med.200134496196611274622
   PubMed Web of Science ®Google Scholar
• RenaultPF.HoofnagleJH.ParkY.et al.Psychiatric complications of long-term interferon-alfa therapy.Arch Intern Med.1987147157715803307672
   PubMed Web of Science ®Google Scholar
• KosekiK.NakanoM.TakaiwaM.KamataT.YosidaJ.Suicidal attempts in three postoperative patients with renal cancer after alpha interferon withdrawal.Nippon Hinyokika Gakkai Zasshi.200091293210689880
   PubMedGoogle Scholar
• WindemuthD.Bacharach-BuhlesM.HoffmannK.AltmeyerP.Depression and suicidal intentions as a side effect of high dosage interferon-alpha therapytwo cases.Hautarzt.19995026626910354918
   PubMed Web of Science ®Google Scholar
• FukunishiK.TanakaH.MaruyamaJ.et al.Burns in a suicide attempt related to psychiatric side effects of interferon.Burns.1998245815839776102
   PubMed Web of Science ®Google Scholar
• Riff letH.VuïlleminE.ObertïF.etal.Suicidal impulses in patients with chronic viral hepatitis C during or after therapy with interferon alpha.Gastroenterol Clin Biol.1998223533579762223
   PubMedGoogle Scholar
• BacqY.Tantaoui ElarakiA.MetmanEH.Suicide in a patient with chronic viral hepatitis C treated with interferon-alpha: favoring role of alcohol?Gastroenterol Clin Biol.1997217977989587525
   PubMedGoogle Scholar
• KrausMR.SchaferA.FallerH.CsefH.ScheurlenM.Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C.Aliment Pharmacol Ther.2002161091109912030950
   PubMed Web of Science ®Google Scholar
• SchrammTM.LawfordBR.MacdonaldGA.CooksleyWG.Sertraline treatment of interferon-alfa-induced depressive disorder.Med J Aust.200017335936111062791
   PubMed Web of Science ®Google Scholar
• FarahA.Interferon-induced depression treated with citalopram.J Clin Psychiatry.20026316616711874221
   PubMed Web of Science ®Google Scholar
• LevensonJL.FallonHJ.Fluoxetine treatment of depression caused by interferon-alpha.Am J Gastroenterol.1993887607618480744
   PubMed Web of Science ®Google Scholar
• WysowskiDK.PittsM.BeitzJ.An analysis of reports of depression and suicide in patients treated with isotretinoin.J Am Acad Dermatol.20014551551911568740
   PubMed Web of Science ®Google Scholar
• WysowskiDK.BeitzJ.Methodological limitations of the study “Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide.”Arch Dermatol.20011371102110311493109
   PubMedGoogle Scholar
• WysowskiDK.PittsM.BeitzJ.Depression and suicide in patients treated with isotretinoin.N Engl J Med.200134446011221610
   PubMed Web of Science ®Google Scholar
• O'DonnellJ.Overview of existing research and information linking isotretinoin (Accutane), depression, psychosis, and suicide.Am J Ther.20031014815912629595
   PubMedGoogle Scholar
• NgCH.TarnMM.HookSJ.Acne, isotretinoin treatment and acute depression.World J Biol Psychiatry.2001215916112587200
   PubMedGoogle Scholar
• NgCH.SchweitzerI.The association between depression and isotretinoin use in acne.Aust N Z J Psychiatry.200337788412534661
   PubMed Web of Science ®Google Scholar
• SvetelMV.SternicNM.FilipovicSR.VojvodicNM.KosticVS.Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa [in Serbo-Croatian].SrpArh Celok Lek.1997125203206
   PubMedGoogle Scholar
• BowersMB Jr.Plasma HVA and MHPG in psychiatric patients with renal failure and levodopa-treated Parkinson's disease.J Neuropsychiatry Clin Neurosci.199684504529116484
   PubMed Web of Science ®Google Scholar
• HaraK.lijimaS.NakamuraS.KameyamaM.Psychiatric symptoms and plasma levodopa dynamics in Parkinson's disease.Rinsho Shinkeigaku.1987278468513665273
   PubMedGoogle Scholar
• NausiedaPA.GlantzR.WeberS.BaumR.KlawansHL.Psychiatric complications of levodopa therapy of Parkinson's disease.Adv Neurol.1984402712776695603
   PubMedGoogle Scholar
• NausiedaPA.TannerCM.KlawansHL.Serotonergically active agents in levodopa-induced psychiatric toxicity reactions.Adv Neurol.19833723326858774
   PubMedGoogle Scholar
• BeasleyBL.NuttJG.DavenportRW.ChaseTN.Treatment with tryptophan of levodopa-associated psychiatric disturbances.Arch Neurol.1980371551567356421
   PubMedGoogle Scholar
• KlawansHL.MoskovitzC.NausiedaPA.WeinerWJ.Levodopa-induced dopaminergic hypersensitivity in the pathogenesis of psychiatric and neurologic disorders.Int J Neurol.197913225236263184
   PubMedGoogle Scholar
• LloydKG.Psychiatric disturbances occurring during levodopa therapy of Parkinson's disease.Prim Care.19774561575264230
   PubMedGoogle Scholar
• LinJT.ZieglerDK.Psychiatric symptoms with initiation of carbidopalevodopa treatment.Neurology.197626699700945518
   PubMed Web of Science ®Google Scholar
• GulmannNC.KorsgaardS.Psychiatric side-effects of levodopa treatment.Ugeskr Laeger.1976138110511071265908
   PubMedGoogle Scholar
• SathananthanG.AngristBM.GershonS.Response threshold to levodopa in psychiatric patients.Biol Psychiatry.197371391464584028
   PubMed Web of Science ®Google Scholar
• Yaryura-TobiasJA.DiamondB.MerlisS.Psychiatric manifestations of levodopa.Can Psych iatr Assoc J.197217(suppl 2)SS123
   Google Scholar
• GoodwinFK.Psychiatric side effects of levodopa in man.JAMA.1971218191519205000569
   PubMed Web of Science ®Google Scholar
• KnoppW.Psychiatric changes in patients treated with levodopa. I. The clinical experiment.Neurology.1970202330
   PubMed Web of Science ®Google Scholar
• CelesiaGG.BarrAN.Psychosis and other psychiatric manifestations of levodopa therapy.Arch Neurol.1970231932005456717
   PubMed Web of Science ®Google Scholar
• RemickRA.GimbarzevskyB.Manic reaction to lidocaine anesthesia.J Clin Psychopharmacol.1990104424432286718
   PubMed Web of Science ®Google Scholar
• Basile FilhoA.PassosHV.AldrighiJR.Madel JuniorJA.Acute psychotic reactions and speech disorders induced by the rapid intravenous injection of lidocaine.Rev Paul Med.19861042293563280
   PubMedGoogle Scholar
• TurnerWM.Lidocaine and psychotic reactions.Ann Intern Med.1982971491507092001
   PubMed Web of Science ®Google Scholar
• HumbertP.GirardînP.AubinF.Fear of dying after intra-keloid injection of triamcinolone acetonide and lidocaine: Hoigne's syndrome.Ann Dermatol Venereol.200112876211486792
   PubMed Web of Science ®Google Scholar
• SaravaySM.MarkeJ.SteinbergMD.RabinerCJ.“Doom anxiety” and delirium in lidocaine toxicity.Am J Psych ia try.1987144159163
   PubMed Web of Science ®Google Scholar
• LebainP.JuliardC.DavyJP.DollfusS.Neuropsychiatrie symptoms in preventive antimalarial treatment with mefloquine: apropos of 2 cases [in French].Encéphale.2000266770
   PubMed Web of Science ®Google Scholar
• CroftAM.WorldMJ.Neuropsychiatrie reactions with mefloquine chemoprophylaxis.Lancet.19963473268569381
   PubMed Web of Science ®Google Scholar
• SowunmïA.AdioRA.OduolaAM.OgundahunsïOA.SalakoLA.Acute psychosis after mefloquine. Report of six cases.Trop Geogr Med.1995471791808560592
   PubMedGoogle Scholar
• SpensleyJ.Folie à deux with methylphenidate psychosis.J Nerv Ment Dis.19721552882905073360
   PubMed Web of Science ®Google Scholar
• RosenfeldAA.Depression and psychotic regression following prolonged methylphenidate use and withdrawal: case report.Am J Psychiatry.1979136226228760559
   PubMed Web of Science ®Google Scholar
• Koehler-TroyC.StroberM.MalenbaumR.Methylphenidate-induced mania in a prepubertal child.J Clin Psychiatry.1986475665673771504
   PubMed Web of Science ®Google Scholar
• LuML.PanJJ.TengHW.SuKP.ShenWW.Metoclopramide-induced supersensitivity psychosis.Ann Pharmacother.2002361387139012196057
   PubMed Web of Science ®Google Scholar
• AnfinsonTJ.Akathisia, panic, agoraphobia, and major depression following brief exposure to metodopramide.Psychopharmacol Bull.200236829312397849
   PubMedGoogle Scholar
• FriendKD.YoungRC.Late-onset major depression with delusions after metodopramide treatment.Am J Geriatr Psychiatry.1997579829169248
   PubMed Web of Science ®Google Scholar
• JibikiI.MaedaT.YamaguchiN.Metoclopramide-induced parkinsonism and depression.Acta Neurol (Napoli).1992141301331414557
   PubMedGoogle Scholar
• ShearerRM.BownesIT.CurranP.Tardive akathisia and agitated depression during metodopramide therapy.Acta Psych iatr Sea nd.198470428431
   PubMed Web of Science ®Google Scholar
• HerzogP.Depression after metodopramide medication.Harefuah.19821033743757183497
   PubMedGoogle Scholar
• SchreiberW.SpernalJ.Metronidazole-induced psychotic disorder.Am J Psychiatry.1997154117011719247414
   PubMed Web of Science ®Google Scholar
• SchentagJJ.ZiemniakJA.GrecoJM.RaînsteïnM.BuckleyRJ.Mental confusion in a patient treated with metronidazole: a concentration-related effect?Pharmacotherapy.198223843877167392
   PubMed Web of Science ®Google Scholar
• TaylorJAT.Metronidazole - a new agent for combined somatic and psychic therapy of alcoholism.Bull Los Angeles Neurol Soc.19642915816214217759
   PubMedGoogle Scholar
• CinaSJ.RussellRA.ConradïSE.Sudden death due to metronidazole/ethanol interaction.Am J Forensic Med Pa thol.199617343346
   PubMed Web of Science ®Google Scholar
• WilliamsCS.WoodcockKR.Do ethanol and metronidazole interact to produce a disulfiram-like reaction?Ann Pharmacother.20003425525710676835
   PubMed Web of Science ®Google Scholar
• McCahillME.BraffDL.Atypical postpartum psychosis possibly associated with metronidazole therapy.J Earn Pract.198827323325
   Google Scholar
• KanofPD.AronsonMJ.NessR.Organic mood syndrome associated with detoxification from methadone maintenance.Am J Psychiatry.19931504234288434657
   PubMed Web of Science ®Google Scholar
• CamachoA.MatthewsSC.DimsdaleJE.“Invisible” synthetic opiates and acute psychosis.N Engl J Med.200134546911496869
   PubMed Web of Science ®Google Scholar
• ShreeramSS.McDonaldT.DennisonS.Psychosis after ultrarapid opiate detoxification.Am J Psychiatry.200115897011384923
   PubMed Web of Science ®Google Scholar
• DavisA.YudofskyB.uidwaiS.Acute psychosis associated with butorphanol.J Neuropsychiatry Clin Neurosci.1998102362379608418
   PubMed Web of Science ®Google Scholar
• LevinsonI.GalynkerII.RosenthalRN.Methadone withdrawal psychosis.J Clin Psychiatry.19955673767852256
   PubMed Web of Science ®Google Scholar
• ChristieJM.eadeWR.MarkowskyS.Paranoid psychosis after intrathecal morphine.Anesth Analg.199377129812998250329
   PubMed Web of Science ®Google Scholar
• SlapGB.Oral contraceptives and depression: impact, prevalence and cause.J Adoiesc Health Care.198125364
   PubMedGoogle Scholar
• MoIIerSE.Effect of oral contraceptives on tryptophan and tyrosine availability: evidence for a possible contribution to mental depression.Neuropsychobiology.198171922007266825
   PubMed Web of Science ®Google Scholar
• BizjakED.NolanPE Jr.BrodyEA.GallowayJM.Procainamide-induced psychosis: a case report and review of the literature.Ann Pharmacother.19993394895110492498
   PubMed Web of Science ®Google Scholar
• HarringtonL.Procainamide-induced psychosis.Crit Care Nurse.19931370728112099
   PubMedGoogle Scholar
• SchubertDS.GabïnetL.HersheyLA.Psychosis induced by sustainedrelease procainamide.Can Med Assoc J.1984131118811906498664
   PubMed Web of Science ®Google Scholar
• MenkenM.Procainamide-induced psychosis.JAMA.197924111071108762759
   PubMed Web of Science ®Google Scholar
• McCrumID.GuidryJR.Procainamide-induced psychosis.JAMA.197824012651266567255
   PubMed Web of Science ®Google Scholar
• SoutulloCA.CottinghamEM.KeckPE Jr.Psychosis associated with pseudoephedrine and dextromethorphan.J Am Acad Child Adoiesc Psychiatry.19993814711472
   PubMed Web of Science ®Google Scholar
• RobergeRJ.HiraniKH.RowlandPL 3rd.BerkeleyR.KrenzelokEP.Dextromethorphan- and pseudoephedrine-induced agitated psychosis and ataxia: case reportJ Emerg Med.19991728528810195488
   PubMed Web of Science ®Google Scholar
• ReevesRR.PinkofskyHB.Postpartum psychosis induced by bromocriptine and pseudoephedrine.J Earn Pract.199745164166
   Google Scholar
• TaylorDM.O'TooleKS.AubleTE.RyanCM.ShermanDR.The psychometric and cardiac effects of pseudoephedrine in the hyperbaric environment.Pharmacotherapy.2000201045105010999495
   PubMed Web of Science ®Google Scholar
• JohnsonAG.DayRO.SeldonWA.Afunctional psychosis precipitated by quinidine.Med J Aust.199015347492381359
   PubMed Web of Science ®Google Scholar
• DeleuD.SchmeddingE.Acute psychosis as idiosyncratic reaction to quinidine: report of two cases.Br Med J (Clin Res Ed),198729410011002
   PubMedGoogle Scholar
• DefoinJF.DebonneT.RambourgMO.et al.Acute psychiatric syndrome and quinolones.J Toxicol Clin Exp.1990104694722135062
   PubMedGoogle Scholar
• OkadaF.Depression after treatment with thiazide diuretics for hypertension.Am J Psychiatry.1985142110111024025632
   PubMed Web of Science ®Google Scholar
• VisapaaJP.TillonenJS.KaihovaaraPS.SalaspuroMP.Lack of disulfiramlike reaction with metronidazole and ethanol.Ann Pharmacother.20023697197412022894
   PubMed Web of Science ®Google Scholar
• Medical EconomicsStaff ed.Physicians' Desk Reference (PDR).Montvale, NJ: Medical Economics Company2003
   Google Scholar
• JacobsDG.DeutschNL.BrewerM.Suicide, depression, and isotretinoin: is there a causal link?J Am Acad Dermatol.200145S168S17511606949
   PubMed Web of Science ®Google Scholar
• JickSS.KremersHM.Vasilakis-ScaramozzaC.Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide.Arch Dermatol.20001361231123611030769
   PubMedGoogle Scholar
• GuptaMA.GuptaAK.Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis.Br J Dermatol.19981398468509892952
   PubMed Web of Science ®Google Scholar
• RubïnowDR.PeckGL.SquillaceKM.GanttGG.Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin.J Am Acad Dermatol.19871725322956296
   PubMed Web of Science ®Google Scholar
• RussoS.KemaIP.HaagsmaEB.et al.Irritability rather than depression during interferon treatment is linked to increased tryptophan catabolism. Poster at the European Congress of Neuropsychopharmacology (ECNP); Barcelona, Spain. 2002
   Google Scholar
• O'ConnorNT.Interferon beta and suicide in multiple sclerosis.Lancet.1996347141714188637378
   PubMed Web of Science ®Google Scholar
• HallRC.PopkinMK.StïckneySK.etal.Presentation of the steroid psychoses.J Nerv Mental Dis.1979167229236
   PubMed Web of Science ®Google Scholar
• AhmadM.RasulFM.Steroid-induced psychosis treated with haloperidol in a patient with active chronic obstructive pulmonary disease.Am J Emerg Med.19991773510597101
   PubMed Web of Science ®Google Scholar
• KimballCP.Psychological dependency on steroids?Ann Intern Med.1971751111135091550
   PubMed Web of Science ®Google Scholar
• DixonRB.ChristyNP.On the various forms of corticosteroid withdrawal syndrome.Am J Med.1980682242307355893
   PubMed Web of Science ®Google Scholar
• FaigenbaumAD.ZaichkowskyLD.GardnerDE.MicheliLJ.Anabolic steroid use by male and female middle school students.Pediatrics.1998101E69565439
   PubMed Web of Science ®Google Scholar
• NilssonS.Androgenic anabolic steroid use among male adolescents in Falkenberg.Eur J Clin Pharmacol.1995489117621856
   PubMed Web of Science ®Google Scholar
• DuRantRH.EscobedoLG.HeathGW.Anabolic-steroid use, strength training, and multiple drug use among adolescents in the United States.Pediatrics.199596(1 pt 1)23287596717
   PubMed Web of Science ®Google Scholar
• Perez-StableEJ.HallidayR.GardinerPS.etal.The effects of propranolol on cognitive function and quality of life: a randomized trial among patients with diastolic hypertension.Am J Med.200010835936510759091
   PubMed Web of Science ®Google Scholar
• KoDT.HébertPR.CoffeyCS.SedrakyanA.CurtisJP.KrumholzHM.Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction.JAMA.200228835135712117400
   PubMed Web of Science ®Google Scholar
• TeraoT.Beta-blocker therapy and depression.JAMA.20022881845184612377074
   PubMedGoogle Scholar